Related Experiment Video
Updated: Apr 19, 2026

05:50
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
2.1K
Molecular modelling based target identification for endo-peroxides class of antimalarials
1Academy of Sciences and Innovative Research, India. anilsak@gmail.com.
Combinatorial Chemistry & High Throughput Screening
|December 30, 2014
Summary
Artemisinin resistance poses a challenge to malaria treatment. Molecular docking suggests heme, not PfATP6, is the likely target for artemisinin-derived drugs, aiding future antimalarial drug discovery.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- Artemisinin and endoperoxide drug resistance is a growing threat to malaria control.
- The precise mechanism of action for these antimalarials remains elusive, hindering resistance management and new drug development.
Purpose of the Study:
- To investigate the molecular targets of artemisinin derivatives using computational methods.
- To differentiate between heme and PfATP6 as potential targets for artemisinin-derived endoperoxides.
Main Methods:
- Molecular docking and scoring studies were conducted on a diverse dataset of artemisinin derivatives.
- A homology model for Plasmodium falciparum ATP6 (PfATP6) was constructed using human SERCA1 as a template.
Main Results:
- Docking studies showed a strong correlation between binding energy at the heme site and antimalarial activity (r² = 0.69).
- Conversely, a weak correlation was observed between binding energy at the PfATP6 site and antimalarial activity (r² = 0.12).
Conclusions:
- These findings strongly suggest that heme is the primary molecular target of artemisinin-derived endoperoxides.
- Identifying heme as the target provides crucial insights for understanding drug resistance and designing next-generation antimalarials.
Related Concept Videos
Targets for Drug Action: Overview
12.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
12.0K
Anthelminthic Agents
90
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
90
Pharmacogenomics: Identification of New Drug Targets
98
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98
Antifungal Agents
103
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
103

